Head-to-head · free
Neuronetics, Inc. vs Tempus AI, Inc.
STIM vs TEM — return on capital, cash generation, margins and balance sheet side by side.
STIM
1 / 7
measures where STIM leads
TEM
6 / 7
measures where TEM leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | STIM · FY2025 | TEM · FY2025 |
|---|---|---|
| Revenue | $149.2M | $1.3B |
| Net income | (39.0M) | (245.0M) |
| Revenue growth (yearly, multi-year) | 28.1% | 83.4% |
| Free cash flow | — | (239.1M) |
| Free cash flow margin | — | -18.8% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | -155.7% | -89.5% |
| Gross margin | 48.5% | 62.7% |
| Operating margin | -21.1% | -19.9% |
| Net debt / EBITDA | -1.35x | -4.22x |
Figures are as reported by each company; latest fiscal year shown.
Where Neuronetics, Inc.'s cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Tempus AI, Inc.'s cash went (FY2025)
- Capital spending
- $21.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free